Ulinastatin for severe belly infection
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This trial tests a medicine called ulinastatin to see if it can help calm your body's overactive immune response during a serious belly infection. The goal is to reduce organ failure and help you recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a serious infection inside your belly that started within the last 2 days.
- Your doctor has confirmed the infection with a scan (CT, ultrasound, or MRI), surgery, or lab test.
- The infection is causing at least mild organ failure (like breathing or blood pressure issues).
- You are not taking high-dose steroids or have a very weak immune system.
- You do not have severe kidney failure, advanced liver disease, active cancer, or a serious mental illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a fluid called Gelaspan (a gelatin-based IV fluid) is better for treating sepsis patients who need emergency abdominal surgery than standard crystalloid fluids. It checks if you have a belly infection and high lactate levels, and you must not have serious heart, lung, or kidney problems.
This trial tests if N-acetylcysteine, a medicine that helps the liver and fights inflammation, can improve outcomes for adults with a severe infection and liver stress.
This Phase 2 study tests whether Pentaglobin®, a blood-product made from immune proteins, helps critically ill people with severe abdominal infection (peritonitis) after the infection source is surgically cleaned up. It targets patients with signs of strong inflammation and severe illness.
This study tests a blood-cleaning treatment to remove harmful toxins from the blood of people with severe abdominal infections. It might help their organs recover faster.
This trial looks at natural molecules that help the body resolve severe infections. Researchers want to understand how these molecules affect recovery and identify patient types that respond best. It may help improve treatment for people in the ICU with serious infections.
This trial tests if a special fluid given through a vein can protect and repair the lining of your blood vessels during sepsis. Sepsis is a dangerous reaction to an infection that can damage organs. This study aims to see if this treatment helps patients in the intensive care unit (ICU) recover better.
Hear when a new Systemic Inflammatory Response trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.